Michael Tucker, MD
Sports Medicine · Columbus, GANPI 1841232691
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,024 of the $5,684 with a category attached, or 70.8%. CGG Medical Inc accounts for 71.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $4,442 and has fallen 95.1% since, to $220 in 2025.
Across 64 payments — averaging $88.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CGG Medical Inc$4K
- Stryker$474
- Arthrex$361
- Amgen$282
- Johnson & Johnson$181
- Medtronic$109
- plus $223 from 9 others
What the payments were for
- Travel & lodging$4,02471%
- Food & beverage$1,65929%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CGG Medical Inc | 3 | $4,054 |
| Stryker | 5 | $474 |
| Arthrex | 5 | $361 |
| Amgen(2 entities) | 34 | $282 |
| Johnson & Johnson | 3 | $181 |
| Medtronic | 2 | $109 |
| Pacira Therapeutics, Inc. | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Orthofix Medical, Inc. | 2 | $26 |
| Viiv Healthcare Company | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| Paragon 28, Inc. | 1 | $19 |
| Next Science LLC | 1 | $12 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AEQUALIS PERFORM REVERSED$284
- RIGIDLOOP$111
- MAKO$100
How this compares
$5,684 in reported general payments places this provider in the 70th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 32 | $6,183 |
| Enoxaparin Sodium | 81 | $5,893 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 322 | $3,705 |
| Celecoxib | 159 | $2,518 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 166 | $1,452 |
| Meloxicam | 638 | $1,415 |
| Cephalexin | 130 | $936 |
| Methylprednisolone | 130 | $773 |
| Tramadol Hcl | 72 | $311 |
| Gabapentin | 31 | $192 |
| Ondansetron Hcl | 22 | $170 |
| Zolpidem Tartrate | 29 | $129 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Columbus
- Jacob DunnColumbus$42K
- Dipal Chatterjee-BerfroidColumbus$27K
- Bradley YoungColumbus$23K
- Champ BakerColumbus$12K
- Abdulaziz KhurshedColumbus$10K
- Frederick FlandryColumbus$9K
- John XerogeanesAtlanta$4M
- Joseph BurnsAlpharetta$376K
- Sameh LabibBrookhaven$280K
- Spero KarasAtlanta$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.